Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Obstetrics and Gynecology ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Hypoactive sexual desire disorder in postmenopausal women: US results from the Women's International Study of Health and Sexuality (WISHeS).Menopause. 2006; 13: 46-56
- Sexual dysfunction in the United States: prevalence and predictors.JAMA. 1999; 281: 537-544
- Sex, health, and years of sexually active life gained due to good health: evidence from two US population based cross sectional surveys of ageing.BMJ. 2010; 340: c810
- Sexual functioning and practices in a multi-ethnic study of midlife women: baseline results from SWAN.J Sex Res. 2003; 40: 266-276
- Sexual activity in midlife women: importance of sex matters.JAMA Intern Med. 2014; 174: 631-633
- Sexual satisfaction and the importance of sexual health to quality of life throughout the life course of U.S. adults.J Sex Med. 2016; 13: 1642-1650
- Sexual problems and distress in United States women: prevalence and correlates.Obstet Gynecol. 2008; 112: 970-978
- DSM-5 task force. Diagnostic and statistical manual of mental disorders: DSM-5.5th edition. American Psychiatric Association, Washington, DC2013
- The DSM diagnostic criteria for hypoactive sexual desire disorder in women.Arch Sex Behav. 2010; 39: 221-239
- Response of the DSM-V sexual dysfunctions subworkgroup to commentaries published in JSM.J Sex Med. 2010; 7: 2382-2387
- Should sexual desire and arousal disorders in women be merged?.Arch Sex Behav. 2011; 40 ([author reply: 221–5]): 217-219
- Female sexual interest/arousal disorder: a diagnosis out of thin air.Arch Sex Behav. 2014; 43: 1227-1229
- Definitions of sexual dysfunctions in women and men: a consensus statement from the Fourth International Consultation on Sexual Medicine 2015.J Sex Med. 2016; 13: 135-143
- Are changes in sexual functioning during midlife due to aging or menopause?.Fertil Steril. 2001; 76: 456-460
- Change in sexual functioning over the menopausal transition: results from the Study of Women's Health Across the Nation.Menopause. 2017; 24: 379-390
- Association of lifestyle and relationship factors with sexual functioning of women during midlife.J Sex Med. 2009; 6: 1358-1368
- Human sexual response.Little, Brown & Co, Boston1966
- The female sexual response: a different model.J Sex Marital Ther. 2000; 26: 51-65
- Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society.J Sex Med. 2014; 11: 2865-2872
- The sexual health approach in postmenopause: the five-minutes study.Maturitas. 2018; 108: 31-36
- A randomized, multicenter, double-blind study to evaluate the safety and efficacy of estradiol vaginal cream 0.003% in postmenopausal women with dyspareunia as the most bothersome symptom.Menopause. 2018; 25: 133-138
- Comparison of intravaginal 6.5mg (0.50%) prasterone, 0.3mg conjugated estrogens and 10mug estradiol on symptoms of vulvovaginal atrophy.J Steroid Biochem Mol Biol. 2017; 174: 1-8
- Vaginal microbiome and epithelial gene array in post-menopausal women with moderate to severe dryness.PLoS One. 2011; 6: e26602
- The female pelvic floor through midlife and aging.Maturitas. 2013; 76: 230-234
- Sexual function after prolapse repair.Curr Opin Obstet Gynecol. 2017; 29: 343-348
- Vaginal estrogen for genitourinary syndrome of menopause: a systematic review.Obstet Gynecol. 2014; 124: 1147-1156
- Female sexual dysfunction and diabetes: a systematic review and meta-analysis.J Sex Med. 2013; 10: 1044-1051
- Female sexual dysfunction in essential hypertension: a common problem being uncovered.J Hypertens. 2006; 24: 2387-2392
- Does hypertension and its pharmacotherapy affect the quality of sexual function in women?.Am J Hypertens. 2000; 13: 640-647
- A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results.JAMA. 1982; 247: 1707-1714
- Antihypertensive medications and sexual function in women: baseline data from the SBP intervention trial (SPRINT).J Hypertens. 2016; 34: 1224-1231
- Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertension Study (TOMHS).Hypertension. 1997; 29: 8-14
- Effect of antihypertensives on sexual function and quality of life: the TAIM Study.Ann Intern Med. 1991; 114: 613-620
- Effect of felodipine with irbesartan or metoprolol on sexual function and oxidative stress in women with essential hypertension.J Hypertens. 2012; 30: 210-216
- Study of sexual functioning determinants in breast cancer survivors.Breast J. 2005; 11: 440-447
- Sexual functioning in long-term breast cancer survivors treated with adjuvant chemotherapy.Breast Cancer Res Treat. 2002; 75: 241-248
- Body image and sexual problems in young women with breast cancer.Psychooncology. 2006; 15: 579-594
- Sexual function after breast cancer.J Sex Med. 2011; 8: 294-302
- Psychosocial problems among younger women with breast cancer.Psychooncology. 2004; 13: 295-308
- Life after breast cancer: understanding women's health-related quality of life and sexual functioning.J Clin Oncol. 1998; 16: 501-514
- Quality of life among younger women with breast cancer.J Clin Oncol. 2005; 23: 3322-3330
- Factors related to sexual function in postmenopausal women with a history of breast cancer.Menopause. 2001; 8: 111-119
- Sexual dysfunction in arterial hypertension women: the role of depression and anxiety.J Affect Disord. 2015; 181: 96-100
- Blood pressure, sexual activity, and dysfunction in women with hypertension: baseline findings from the Systolic Blood Pressure Intervention Trial (SPRINT).J Sex Med. 2016; 13: 1333-1346
- Antidepressant medications: a review of the evidence for drug-induced sexual dysfunction.J Affect Disord. 2002; 69: 119-140
- Prevalence of sexual dysfunction among newer antidepressants.J Clin Psychiatry. 2002; 63: 357-366
- Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis.J Clin Psychopharmacol. 2009; 29: 259-266
- Mirtazapine substitution in SSRI-induced sexual dysfunction.J Clin Psychiatry. 2000; 61: 356-360
- Sildenafil treatment of women with antidepressant-associated sexual dysfunction: a randomized controlled trial.JAMA. 2008; 300: 395-404
- Bupropion treatment of serotonin reuptake antidepressant-associated sexual dysfunction.Ann Clin Psychiatry. 1997; 9: 241-245
- Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles.Arch Gen Psychiatry. 2006; 63: 385-390
- Major depression during and after the menopausal transition: Study of Women's Health Across the Nation (SWAN).Psychol Med. 2011; 41: 1879-1888
- Depressive symptoms during the menopausal transition: the Study of Women's Health Across the Nation (SWAN).J Affect Disord. 2007; 103: 267-272
- Sexual function in the late postmenopause: a decade of follow-up in a population-based cohort of Australian women.J Sex Med. 2014; 11: 2029-2038
- Sexual dysfunction in major depression.CNS Spectr. 2006; 11: 19-23
- Sexual function, dysfunction, and sexual distress in a prospective, population-based sample of mid-aged, Australian-born women.J Sex Med. 2008; 5: 2291-2299
- Longitudinal changes in sexual functioning as women transition through menopause: results from the Study of Women's Health Across the Nation.Menopause. 2009; 16: 442-452
- Lifetime depression history and sexual function in women at midlife.Arch Sex Behav. 2004; 33: 539-548
- Changes in sexual function among midlife women: "I'm older… and I'm wiser".Menopause. 2018; 25: 286-292
- The relationship between daily hassles and sexual function in men and women.J Sex Marital Ther. 2014; 40: 379-395
- The association between daily stress and sexual activity.J Fam Psychol. 2010; 24: 271-279
- Sexual assault history and women's reproductive and sexual health.Psychol Women Q. 1996; 20: 101-121
- Prevalence and characteristics of sexual violence, stalking, and intimate partner violence victimization--national intimate partner and sexual violence survey, United States, 2011.MMWR Surveill Summ. 2014; 63: 1-18
- Sexual function and satisfaction in adults based on the definition of child sexual abuse.J Sex Med. 2007; 4: 1312-1321
- Screening and counseling for intimate partner violence: a vision for the future.J Womens Health (Larchmt). 2015; 24: 57-61
- Using trauma theory to design service systems: new directions for mental health services. Jossey-Bass, San Francisco (CA)2001
- Sexual satisfaction in premarital relationships: associations with satisfaction, love, commitment, and stability.J Sex Res. 2002; 39: 190-196
- Relationship satisfaction and sexual satisfaction: a longitudinal study of individuals in long-term relationships.J Sex Res. 2005; 42: 113-118
- Female sexual function varies over time and is dependent on partner-specific factors: a population-based longitudinal analysis of six sexual function domains.Psychol Med. 2017; 47: 341-352
- Sexual experience of female partners of men with erectile dysfunction: the female experience of men's attitudes to life events and sexuality (FEMALES) study.J Sex Med. 2005; 2: 675-684
- Flibanserin in postmenopausal women with hypoactive sexual desire disorder: results of the PLUMERIA study.J Sex Med. 2017; 14: 834-842
- Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the VIOLET Study.J Sex Med. 2012; 9: 1074-1085
- Efficacy of flibanserin in women with hypoactive sexual desire disorder: results from the BEGONIA trial.J Sex Med. 2013; 10: 1807-1815
- Continued efficacy and safety of flibanserin in premenopausal women with Hypoactive Sexual Desire Disorder (HSDD): results from a randomized withdrawal trial.J Sex Med. 2011; 8: 3160-3172
- Efficacy and safety of Flibanserin for the treatment of hypoactive sexual desire disorder in women: a systematic review and meta-analysis.JAMA Intern Med. 2016; 176: 453-462
- Transdermal testosterone treatment in women with impaired sexual function after oophorectomy.N Engl J Med. 2000; 343: 682-688
- Testosterone patch for low sexual desire in surgically menopausal women: a randomized trial.Obstet Gynecol. 2005; 105: 944-952
- Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial.Arch Intern Med. 2005; 165: 1582-1589
- Testosterone treatment of HSDD in naturally menopausal women: the ADORE study.Climacteric. 2010; 13: 121-131
- Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 Study.Menopause. 2006; 13: 770-779
- Testosterone for low libido in postmenopausal women not taking estrogen.N Engl J Med. 2008; 359: 2005-2017
- Efficacy and safety of transdermal testosterone in postmenopausal women with hypoactive sexual desire disorder: a systematic review and meta-analysis.Fertil Steril. 2017; 107: 475-482.e5
- Clinical review: the benefits and harms of systemic testosterone therapy in postmenopausal women with normal adrenal function: a systematic review and meta-analysis.J Clin Endocrinol Metab. 2014; 99: 3543-3550
- A double-blind, randomized, placebo-controlled trial of the effect of testosterone cream on the sexual motivation of menopausal hysterectomized women with hypoactive sexual desire disorder.Climacteric. 2007; 10: 335-343
- Testosterone dose-response relationships in hysterectomized women with or without oophorectomy: effects on sexual function, body composition, muscle performance and physical function in a randomized trial.Menopause. 2014; 21: 612-623
- Risk of stroke in women with use of testosterone-containing hormone replacement therapy.Stroke. 2017; 48: 197
- Testosterone and breast cancer.J Sex Med. 2010; 7 ([author reply: 1036–7]): 1035-1036
- Breast cancer incidence in postmenopausal women using testosterone in addition to usual hormone therapy.Menopause. 2004; 11: 531-535
- The incidence of invasive breast cancer among women prescribed testosterone for low libido.J Sex Med. 2009; 6: 1850-1856
- A mindfulness-based group psychoeducational intervention targeting sexual arousal disorder in women.J Sex Med. 2008; 5: 1646-1659
- Group mindfulness-based therapy significantly improves sexual desire in women.Behav Res Ther. 2014; 57: 43-54
- An online, mindfulness-based, cognitive-behavioral therapy for female sexual difficulties: impact on relationship functioning.J Sex Marital Ther. 2014; 40: 561-576
- Effects of mindfulness training on body awareness to sexual stimuli: implications for female sexual dysfunction.Psychosom Med. 2011; 73: 817-825
- Mindfulness-based sex therapy improves genital-subjective arousal concordance in women with sexual desire/arousal difficulties.Arch Sex Behav. 2016; 45: 1907-1921
- Vulvar and vaginal atrophy in four European countries: evidence from the European REVIVE Survey.Climacteric. 2016; 19: 188-197
- Vaginal atrophy of women in postmenopause. Results from a multicentric observational study: the AGATA study.Maturitas. 2016; 83: 40-44
- The women's EMPOWER survey: identifying women's perceptions on vulvar and vaginal atrophy and its treatment.J Sex Med. 2017; 14: 413-424
- Vulvar and vaginal atrophy in postmenopausal women: findings from the REVIVE (REal Women's VIews of Treatment Options for Menopausal Vaginal ChangEs) survey.J Sex Med. 2013; 10: 1790-1799
- Female sexual function improved with ospemifene in postmenopausal women with vulvar and vaginal atrophy: results of a randomized, placebo-controlled trial.Climacteric. 2015; 18: 226-232
- Ospemifene, a non-oestrogen selective oestrogen receptor modulator for the treatment of vaginal dryness associated with postmenopausal vulvar and vaginal atrophy: a randomised, placebo-controlled, phase III trial.Maturitas. 2014; 78: 91-98
- One-year long-term safety extension study of ospemifene for the treatment of vulvar and vaginal atrophy in postmenopausal women with a uterus.Menopause. 2013; 20: 418-427
- Long-term safety of ospemifene (52-week extension) in the treatment of vulvar and vaginal atrophy in hysterectomized postmenopausal women.Maturitas. 2014; 77: 274-281
- Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause.Menopause. 2016; 23: 243-256
- Patient acceptability and satisfaction with a low-dose solubilized vaginal estradiol softgel capsule, TX-004HR.Menopause. 2017; 24: 894-899
- TX-004HR improves sexual function as measured by the female sexual function index in postmenopausal women with vulvar and vaginal atrophy: the REJOICE trial.J Sex Med. 2016; 13: 1930-1937
- Vulvo-vaginal atrophy: a new treatment modality using thermo-ablative fractional CO2 laser.Maturitas. 2015; 80: 296-301
- Sexual function after fractional microablative CO(2) laser in women with vulvovaginal atrophy.Climacteric. 2015; 18: 219-225
- Epidemiology/risk factors of sexual dysfunction.J Sex Med. 2004; 1: 35-39
- Sexual dysfunction in women with type 1 diabetes: a controlled study.Diabetes Care. 2002; 25: 672-677
- Sexual function in men and women with neurological disorders.Lancet. 2007; 369: 512-525
- Alcohol, drugs and sexual function: a review.J Psychoactive Drugs. 2001; 33: 223-232
- Sexual functioning throughout menopause: the perceptions of women in a British cohort.Menopause. 2006; 13: 880-890
- Sexual dysfunction in women with cancer.Fertil Steril. 2013; 100: 916-921
- Sexuality after breast cancer: a review.Maturitas. 2010; 66: 397-407
- Longitudinal study of sexual function and vaginal changes after radiotherapy for cervical cancer.Int J Radiat Oncol Biol Phys. 2003; 56: 937-949
- Bladder, bowel and sexual function after hysterectomy for benign conditions.Br J Obstet Gynaecol. 1997; 104: 983-987
- Outcomes of hysterectomy.Clin Obstet Gynecol. 1997; 40: 939-946
- Sexual dysfunction in women with ESRD requiring hemodialysis.Clin J Am Soc Nephrol. 2012; 7: 974-981
- Sexual dysfunction in men and women with chronic kidney disease and end-stage kidney disease.Adv Ren Replace Ther. 2003; 10: 48-60
- Sexual dysfunction is common in women with lower urinary tract symptoms and urinary incontinence: results of a cross-sectional study.Eur Urol. 2004; 45 ([discussion: 648]): 642-648
- Sexual function among women with urinary incontinence and pelvic organ prolapse.Am J Obstet Gynecol. 2004; 191: 751-756
- Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine.J Clin Psychiatry. 2000; 61: 276-281
- A placebo-controlled comparison of the effects on sexual functioning of bupropion sustained release and fluoxetine.Clin Ther. 2001; 23: 1040-1058
- Sexual dysfunction in women on adjuvant endocrine therapy after breast cancer.Menopause. 2013; 20: 162-168
- The impact of aromatase inhibitors on sexual functioning: current knowledge and future research directions.Breast. 2008; 17: 436-440
- Reproductive and sexual function after platinum-based chemotherapy in long-term ovarian germ cell tumor survivors: a Gynecologic Oncology Group Study.J Clin Oncol. 2007; 25: 2792-2797
- Effect of valsartan and atenolol on sexual behavior in hypertensive postmenopausal women.Am J Hypertens. 2004; 17: 77-81
- Reversible anorgasmia with topiramate therapy for migraine.Neurology. 2005; 65: 1333-1334
- Sexual dysfunction, sex steroid hormone abnormalities, and depression in women with epilepsy treated with antiepileptic drugs.Epilepsy Behav. 2005; 6: 360-365
- Sexual side effects of alprazolam.Am J Psychiatry. 1987; 144: 254-255
- Lithium, benzodiazepines, and sexual function in bipolar patients.Am J Psychiatry. 1992; 149: 801-805
Article info
Footnotes
Disclosure Statement: Dr R. Hess reports no disclosures; Dr G.S. Neal-Perry is a member of the Scientific Advisory Board for Astellas and a past Data and Safety Monitoring Board member for Ferring Pharmaceuticals. Dr H.N. Thomas is funded by a grant from the National Institute of Health’s National Institute on Aging; grant number K23AG052628.
Identification
Copyright
© 2018 Elsevier Inc. All rights reserved.
